Prepare for your visit

Kyle Marra

Temecula, CA · NPI 1639873003

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$1,003.69

in general payments reported to CMS, 2019-2025 · $305 in 2025

The $305 reported for 2025 was more than what a typical provider received nationally.

Who reported paying

General payments only, top 3 by amount.

Alcon Vision LLC $227.00
Abbvie INC. $181.46
Bausch & Lomb Americas INC. $78.14

Drugs and devices associated with these payments

Clareon Xen Glaucoma Treatment System Xipere Hydrus Microstent Unity Xiidra Vyzulta Miebo Ozurdex Centurion

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Kyle Marra listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11692060/kyle-marra